The New Paper

October 22, 2020

Purdue Pharma agrees to guilty plea and settlement for role in opioid epidemic

OxyCotin-maker Purdue Pharma agreed to pay $8B in penalties and plead guilty to three felonies for its role in the opioid epidemic. The agreement, if approved in bankruptcy court, would also call for the company to cease operations in its current form and transfer its assets to a “public benefit company” that would deliver legitimate prescription drugs, provide discounts for overdose rescue drugs, and donate profits toward opioid abatement programs.

More context: The US opioid crisis claimed over 400k lives from 1999 to 2017 (more). 

This story is from the October 22, 2020 edition of The New Paper – a clear, concise daily briefing that makes fact-first news easy to consume. Try it today.